Avid Bioservices Inc (CDMO)

[Couch]

Yeah I had better get out my data dictionary on this one. It just seems so unclear. LOL

our Phase III SUNRISE trial. In fact, with over 90% of the expected enrollment complete, we currently have sufficient patient enrollment based on the assumptions of the study to allow the trial’s planned interim evaluations and final readout based on the primary endpoint of overall survival. Having said that, we do expect to complete enrollment of at least the pre-specified 582 patients over the coming weeks. At this point, the next big milestones really are the interim data analysis from the study, expected to take place during early & mid 2016, with trial unblinding expected toward the end of 2016.